Literature DB >> 4003402

Malignancies due to occupational exposure to benzene.

M Aksoy.   

Abstract

There is no doubt about the leukemogenic effect of benzene in man. The evidence is as follows: (1) The incidence of leukemia in shoeworkers exposed to benzene in a period of 8 years in Istanbul was 13.6/100,000, which is significantly higher than that for leukemia in the general population. (2) Following the phase-out of benzene in Istanbul, the number of leukemic workers decreased and none were reported in the subsequent 3 years. (3) The development of leukemia in pancytopenic patients with benzene exposure was observed in 13 out of 51 patients. (4) The differences in the distribution of the types of leukemia in individuals exposed and in nonexposed groups were as follows: acute leukemia 96.1% in the former group, and 46% in the latter group. The high percentages of acute erythroleukemia and preleukemia were other interesting findings in the exposed group. (5) Two cases of leukemia were observed in a 6-year period at a tire cord manufacturing plant with 550 workers. At one location in the plant the concentration of benzene measured by gas chromatography was nearly 110 ppm. Additionally, we have studied 12 cases of malignant lymphoma, four cases of multiple myeloma, and six cases of lung cancer, all of whom were chronically exposed to benzene. The possible role of benzene in the etiology of these malignancies is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4003402     DOI: 10.1002/ajim.4700070506

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  22 in total

1.  Exposure to benzene in Turkey between 1983 and 1985: a haematological study on 231 workers.

Authors:  M Aksoy; S Ozeriş; H Sabuncu; Y Inanici; R Yanardağ
Journal:  Br J Ind Med       Date:  1987-11

2.  non-Hodgkin's lymphoma and occupation in Sweden: a registry based analysis.

Authors:  M S Linet; H S Malker; J K McLaughlin; J A Weiner; W J Blot; J L Ericsson; J F Fraumeni
Journal:  Br J Ind Med       Date:  1993-01

3.  Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics.

Authors:  Roel Vermeulen; Qing Lan; Luoping Zhang; Laura Gunn; Diane McCarthy; Ronald L Woodbury; Marielena McGuire; Vladimir N Podust; Guilan Li; Nilanjan Chatterjee; Ruidong Mu; Songnian Yin; Nathaniel Rothman; Martyn T Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

4.  Effect of subacute benzene exposure on the activity of two neuropeptide-degrading enzymes in the rat brain.

Authors:  J M de Gandarias; O Casis; J Irazusta; E Echevarría; L Casis
Journal:  Arch Environ Contam Toxicol       Date:  1992-04       Impact factor: 2.804

5.  Leukaemia, lymphoma, and multiple myeloma in seamen on tankers.

Authors:  R I Nilsson; R Nordlinder; L G Hörte; B Järvholm
Journal:  Occup Environ Med       Date:  1998-08       Impact factor: 4.402

6.  A morphological analysis of the short-term effects of benzene on the development of the hematological cells in the bone marrow of mice and the effects of interleukin-1 alpha on the process.

Authors:  R Niculescu; G F Kalf
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

7.  Leukaemia in benzene workers: a retrospective cohort study.

Authors:  S N Yin; G L Li; F D Tain; Z I Fu; C Jin; Y J Chen; S J Luo; P Z Ye; J Z Zhang; G C Wang
Journal:  Br J Ind Med       Date:  1987-02

8.  An update of mortality among chemical workers exposed to benzene.

Authors:  G G Bond; E A McLaren; C L Baldwin; R R Cook
Journal:  Br J Ind Med       Date:  1986-10

9.  A mortality study of Danish stokers.

Authors:  E S Hansen
Journal:  Br J Ind Med       Date:  1992-01

10.  Incidence of leukaemia and lymphoma in young people in the vicinity of the petrochemical plant at Baglan Bay, South Wales, 1974 to 1991.

Authors:  R A Lyons; S P Monaghan; M Heaven; B N Littlepage; T J Vincent; G J Draper
Journal:  Occup Environ Med       Date:  1995-04       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.